Eucerin Brand Launches Medical Grade Actinic Control SPF 100 February 24, 2021 Contact Author Rachel Grabenhofer Close Sponsored According to Beiersdorf, actinic keratosis is the most common precursor to non-melanoma skin cancer, and can be attributed to sun exposure. An especially high sun protection factor (SPF) can therefore protect against sun-induced skin damage and provide compromised skin with the necessary protection. In response, the company has launched Eucerin Actinic Control SPF 100—the first medical device offering from the dermocosmetics brand. The product is designed to adequately protect sun-sensitive skin while also preventing actinic keratosis and non-melanoma skin cancer, thus serving as adjuvant treatment for patients already affected by actinic keratosis.